Gene fusion of egfp & kan and recombinant plasmid construction by red mediated in vivo homologous recombination.
- Author:
Yang WU
1
;
Shan-Hu LI
;
Qing-Guo SHI
;
Dang-Sheng LIU
;
Jian-Guang ZHOU
Author Information
1. Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100850, China.
- Publication Type:Journal Article
- MeSH:
Bacteriophage lambda;
enzymology;
genetics;
DNA, Recombinant;
genetics;
Electroporation;
Escherichia coli;
genetics;
Gene Fusion;
genetics;
Genetic Engineering;
methods;
Green Fluorescent Proteins;
genetics;
metabolism;
Plasmids;
genetics;
Recombinases;
genetics;
metabolism;
Recombination, Genetic
- From:
Chinese Journal of Biotechnology
2007;23(4):598-601
- CountryChina
- Language:Chinese
-
Abstract:
Recombineering, a new genetic engineering technology based on high efficiency in vivo homologous recombination, can be used in target DNA knock-in, knock-out and gene cloning. In the process of gene subcloning mediated by Recombineering technique, high-quality target DNA fragments were difficult to obtain using in vitro overlapping PCR,therefore the efficiency of in vivo homologous recombination was severely interrupted. To solve this problem, some technology improvements have been established based on the principle of Red recombinases. The PCR DNA fragments of egfp and kan genes with complementary sequences on the end of each fragment were co-introduced into a pcDNA3.1 vector and Red recombinases containing E. coli DY331 host cells by electroporation. A recombinant plasmid pcDNA3.1-egfp-kan was screened directly by antibiotic marker. The positive rates can reach to 45%. The EGFP gene expression of pcDNA3.1-egfp-kan can be observed by transient transfection of 293 eukaryotic cells.
